The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study
Background. The aim of this study was to validate the impact of type 2 diabetes (T2D) on the platelet reactivity in patients with acute ST elevation myocardial infarction (STEMI) treated with adenosine diphosphate (ADP) receptor blockers. Methods. A pilot prospective study was performed. Totally 67...
Saved in:
Main Authors: | Matej Samoš, Marián Fedor, František Kovář, Peter Galajda, Tomáš Bolek, Lucia Stančiaková, Jana Fedorová, Ján Staško, Peter Kubisz, Marián Mokáň |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2016/2909436 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Type 2 Diabetes and ADP Receptor Blocker Therapy
by: Matej Samoš, et al.
Published: (2016-01-01) -
Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
by: Dana Prídavková, et al.
Published: (2019-01-01) -
SARS-CoV-2 Infection-Associated Aortic Thrombosis Treated with Oral Factor Xa Inhibition
by: Alena Strýčková, et al.
Published: (2022-01-01) -
Carboxypeptidase B1 in dialyzed chronic kidney disease patients
by: Matej Stančík, et al.
Published: (2025-02-01) -
Infective Aortic Valve Endocarditis Causing Embolic Consecutive ST-Elevation Myocardial Infarctions
by: Kanksha Peddi, et al.
Published: (2019-01-01)